🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07812402
Active, not recruiting Observational

The Effect of Factors Affecting Bone Mineral Density Measurement Results on Osteoporosis Diagnosis and Treatment Decision

NCT07812402 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-09-15
Last updated
2026-09-10

Condition(s) studied

Osteoporosis

Study summary

This is a single-center prospective cross-sectional study with a follow-up period of 6 months. All patients met the inclusion criteria and requested DXA at the outpatient clinics of Ankara Etlik City Hospital Physical Therapy and Rehabilitation Hospital. Sample size was performed using the statistical power analysis program for G\*Power 3.1.9.6 Mac. Based on the study by Tuna et al. aiming to evaluate the rate of poor positioning of patients during DXA and the accuracy of the analysis, the minimum required number of patients (with a 95% working power and 95% confidence interval with a 5% Type 1 and 20% Type 2 margin of error and a 95% working power and 95% confidence interval) was found to be 530. It was decided to include at least 530 patients in the study.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Patients over 18 years of age * Lumbar and proximal femur measurements Exclusion Criteria: * Measurements performed in children * Forearm measurements * Whole-body measurements * Measurements with patient-related uncorrectable sources of error (e.g., scoliosis, stabilization materials)

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Ankara Etlik City Hospital Ankara Ankara
Etlik City Hospital Ankara Yenimahalle

More Ankara Etlik City Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07812402 on ClinicalTrials.gov ↗ ← All trials in Turkey